SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-4.65%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$226M
AUM Growth
+$226M
(+7.3%)
Cap. Flow
+$25.3M
Cap. Flow
% of AUM
11.19%
Top 10 Holdings %
Top 10 Hldgs %
35.32%
Holding
73
New
13
Increased
28
Reduced
11
Closed
15
Top Buys
| 1 |
Gilead Sciences
GILD
|
$5.97M |
| 2 |
Becton Dickinson
BDX
|
$5.31M |
| 3 |
Abbott
ABT
|
$5.23M |
| 4 |
AET
Aetna Inc
AET
|
$5.06M |
| 5 |
McKesson
MCK
|
$4.09M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$7.14M |
| 2 |
Viatris
VTRS
|
$4.87M |
| 3 |
HNT
HEALTH NET INC
HNT
|
$4.22M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
$4.09M |
| 5 |
Amgen
AMGN
|
$3.75M |
Sector Composition
| 1 | Healthcare | 86.82% |
| 2 | Financials | 4.72% |
| 3 | Energy | 1.73% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
1
DELISTED
Aetna Inc
AET
| $10.7M | 4.72% |
95,000
+45,000
| +90% | +$5.06M |
|
2
HCA Healthcare
HCA
$94.5B
| $9.76M | 4.32% |
125,000
-15,000
| -11% | -$1.17M |
|
3
UnitedHealth
UNH
$281B
| $9.67M | 4.28% |
75,000
+25,000
| +50% | +$3.22M |
|
4
Universal Health Services
UHS
$11.6B
| $9.35M | 4.14% |
75,000
+10,000
| +15% | +$1.25M |
|
|
5
McKesson
MCK
$85.4B
| $8.02M | 3.55% |
51,000
+26,000
| +104% | +$4.09M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.96M | 3.08% |
50,000
+20,000
| +67% | +$2.78M |
|
|
7
Becton Dickinson
BDX
$55.3B
| $6.83M | 3.02% |
45,000
+35,000
| +350% | +$5.31M |
|
8
Humana
HUM
$36.5B
| $6.4M | 2.83% |
35,000
+15,000
| +75% | +$2.74M |
|
9
Centene
CNC
$14.3B
| $6.16M | 2.73% |
100,000
+60,000
| +150% | +$3.69M |
|
|
10
Gilead Sciences
GILD
$140B
| $5.97M | 2.64% |
+65,000
| New | +$5.97M |
|
|
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
| $5.9M | 2.61% |
70,000
+43,512
| +164% | +$3.67M |
|
12
Boston Scientific
BSX
$156B
| $5.64M | 2.5% |
300,000
| – | – |
|
13
Cigna
CI
$80.3B
| $5.49M | 2.43% |
40,000
| – | – |
|
14
Chemed
CHE
$6.67B
| $5.42M | 2.4% |
40,000
+15,000
| +60% | +$2.03M |
|
15
Zimmer Biomet
ZBH
$21B
| $5.33M | 2.36% |
50,000
+30,000
| +150% | +$3.2M |
|
|
16
Abbott
ABT
$231B
| $5.23M | 2.31% |
+125,000
| New | +$5.23M |
|
17
Bristol-Myers Squibb
BMY
$96B
| $5.11M | 2.26% |
80,000
+5,000
| +7% | +$319K |
|
18
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.95M | 2.19% |
60,000
+32,114
| +115% | +$2.65M |
|
|
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.64M | 2.05% |
50,000
+15,000
| +43% | +$1.39M |
|
20
Tenet Healthcare
THC
$16.3B
| $4.63M | 2.05% |
160,000
+35,000
| +28% | +$1.01M |
|
21
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.51M | 1.99% |
12,500
+7,500
| +150% | +$2.7M |
|
22
Thermo Fisher Scientific
TMO
$186B
| $4.25M | 1.88% |
30,000
-5,000
| -14% | -$708K |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $4.02M | 1.78% |
15,000
-2,500
| -14% | -$670K |
|
|
CELG
24
DELISTED
Celgene Corp
CELG
| $4M | 1.77% |
40,000
| – | – |
|
|
LHCG
25
DELISTED
LHC Group LLC
LHCG
| $3.91M | 1.73% |
110,000
+22,295
| +25% | +$793K |
|